|
Sign In to gain access to subscriptions and/or personal tools.
|
Augmented myocardial methionine-enkephalin in a murine model of cardiac angiotensin II-overexpression
Olivier WV van den Brink
Department of Cardiothoracic Surgery, Alfred Hospital & Department of Surgery, Monash University, Melbourne, Australia
Lea M Durham Delbridge
Laboratory of Cardiac Phenomics, Department of Physiology, University of Melbourne, Melbourne, Australia
Thierry Pedrazzini
Department of Pharmacology, University of Lausanne, Lausanne, Switzerland
Franklin L Rosenfeldt
Department of Cardiothoracic Surgery, Alfred Hospital & Department of Surgery, Monash University, Melbourne, Australia
Salvatore Pepe
Department of Cardiothoracic Surgery, Alfred Hospital & Department of Surgery, Monash University, Melbourne, Australia, salvatore.pepe@ med.monash.edu.au, Department of Surgery, Central & Eastern Clinical School, Monash University, Commercial Road, Melbourne, Australia
Introduction. The endogenous opioid system has been reported to interact with both the cardiac sympathetic and renin-angiotensin systems in exerting a local regulatory action on the heart.The goal of this investigation was to examine how cardiac levels of enkephalin production are altered in the development of normotensive primary hypertrophy due to elevated intra-cardiac angiotensin II (Ang II) production.
Methods. Atrial and ventricular methionine-enkephalin (ME) levels were measured by quantitative radioimmunoassay in 14 and 28-week-old male transgenic mice (TG1306/1R) and control mice.The TG1306/1R exhibit cardiac specific Ang II overexpression and cardiac hypertrophy, but not hypertension.
Results. TG1306/1R mice had significantly higher heart/body weight ratios H (15—20%) than control littermates at both 14 (p=0.02) and 28 weeks (p=0.04). Relative to controls, ME content was significantly elevated (approximately twofold) in atria and ventricles in the older 28-week TG1306/1R mice only. A significant inverse correlation between heart size and ME level was observed for 28-week TG1306/1R only.
Conclusions. We have provided evidence that a marked elevation of myocardial enkephalin level is observed in the established (but not early) phase of cardiac hypertrophy associated with cardiac-specific Ang II-overexpression.This study identifies a potentially important relationship between two endogenous peptidergic signalling systems involved in the regulation of growth and function of the hypertrophic heart.
Key Words: angiotensin II enkephalin hypertrophy mouse opioid peptide
References
- Levy D., Garrison RJ, Savage DD, Kannel WB, Castelli WP Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-6.[Abstract]
- Vakili BA, Okin PM, Devereux RB Prognostic implications of left ventricular hypertrophy. Am Heart J 2001;141:334-41.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Frey N., Olson EN Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 2003;65:45-79.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Mathew J., Sleight P., Lonn E. et al. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 2001;104:1615-21.[Abstract/Free Full Text]
- Papademetriou V. From hypertension to heart failure. J Clin Hypertens 2004;6:14-17.[CrossRef]
- Dahlof B. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review. J Hum Hypertens 1995;9(Suppl 5):S37-S44.
- Kim S., Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000;52:11-34.[Abstract/Free Full Text]
- Younes A., Pepe S., Barron BA, Spurgeon HA, Lakatta EG, Caffrey JL Cardiac synthesis, processing, and coronary release of enkephalin-related peptides. Am J Physiol 2000;279:H1989-98.[Web of Science]
- Holaday JW Cardiovascular effects of endogenous opiate systems. Annu Rev Pharmacol Toxicol 1983;23:541-94.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Springhorn JP, Claycomb WC Translation of heart preproenkephalin mRNA and secretion of enkephalin peptides from cultured cardiac myocytes. Am J Physiol 1992;263:H1560-H1566.[Web of Science][Medline]
[Order article via Infotrieve]
- Pepe S., Xiao RP, Hohl C., Altschuld R., Lakatta EG 'Cross talk' between opioid peptide and adrenergic receptor signaling in isolated rat heart. Circulation 1997;95:2122-9.[Abstract/Free Full Text]
- Xiao RP, Pepe S., Spurgeon HA, Capogrossi MC, Lakatta EG Opioid peptide receptor stimulation reverses beta-adrenergic effects in rat heart cells. Am J Physiol 1997;272:H797-H805.[Web of Science][Medline]
[Order article via Infotrieve]
- Pepe S., van den Brink OW, Lakatta EG, Xiao RP Crosstalk of opioid peptide receptor and beta-adrenergic receptor signalling in the heart. Cardiovasc Res 2004;63:414-22.[Abstract/Free Full Text]
- Younes A., Pepe S., Yoshishige D., Caffrey JL, Lakatta EG Ischemic preconditioning increases the bioavailability of cardiac enkephalins. Am J Physiol 2005;289:H1652-H1661.[Web of Science]
- Fukuhara M., Matsumura K., Abe I., Fujishima M. Interaction of opioids and vasopressin in central action of angiotensin II in conscious rabbits. Hypertens Res 1998;21:89-95.[Web of Science][Medline]
[Order article via Infotrieve]
- Takai S., Song K., Tanaka T., Okunishi H., Miyazaki M. Antinociceptive effects of angiotensin-converting enzyme inhibitors and an angiotensin II receptor antagonist in mice. Life Sci 1996;59:PL331-PL336.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Henegar JR, Schwartz DD, Jani D. cki JS ANG II-related myocardial damage: role of cardiac sympathetic catecholamines and beta-receptor regulation. Am J Physiol 1998;275: H534-H541.[Web of Science][Medline]
[Order article via Infotrieve]
- Xiang JZ, Linz W., Becker H. et al. Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart. Eur J Pharmacol 1985;113:215-23.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Reid IA Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol 1992;262:E763-E778.[Web of Science][Medline]
[Order article via Infotrieve]
- Mazzolai L., Nussberger J., Aubert JF et al. Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension 1998;31:1324-30.[Abstract/Free Full Text]
- Mazzolai L., Pedrazzini T., Nicoud F., Gabbiani G., Brunner HR, Nussberger J. Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normotensive mice. Hypertension 2000;35:985-91.[Abstract/Free Full Text]
- Domenighetti AA, Wang Q., Egger M., Richards SM, Pedrazzini T., Delbridge LM Angiotensin II-mediated phenotypic cardiomyocyte remodeling leads to age-dependent cardiac dysfunction and failure. Hypertension 2005;46:426-32.[Abstract/Free Full Text]
- Porrello ER, Huggins CE, Curl CI et al. Elevated dietary sodium intake exacerbates myocardial hypertrophy associated with cardiac-specific overproduction of angiotensin II. JRAAS 2004;5:169-75.[Medline]
[Order article via Infotrieve]
- Pellieux C., Aasum E., Larsen TS et al. Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway. J Mol Cell Cardiol 2006;41:459-66.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Domenighetti AA, Boixel C., Cefai D., Abriel H., Pedrazzini T. Chronic angiotensin II stimulation in the heart produces an acquired long QT syndrome associated with IK1 potassium current downregulation. J Mol Cell Cardiol 2007;42:63-70.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Schunkert H., Sadoshima J., Cornelius T. et al. Angiotensin II-induced growth responses in isolated adult rat hearts. Evidence for load-independent induction of cardiac protein synthesis by angiotensin II. Circ Res 1995;76:489-97.[Abstract/Free Full Text]
- Zimmer HG Catecholamine-induced cardiac hypertrophy: significance of proto-oncogene expression. J Mol Med 1997;75:849-59.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Boluyt MO, Younes A., Caffrey JL et al. Age-associated increase in rat cardiac opioid production. Am J Physiol 1993;265:H212-H218.[Web of Science][Medline]
[Order article via Infotrieve]
- Caffrey JL, Boluyt MO, Younes A. et al. Aging,cardiac proenkephalin mRNA and enkephalin peptides in the Fisher 344 rat. J Mol Cell Cardiol 1994;26:701-11.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- McLaughlin PJ Regulation of DNA synthesis of myocardial and epicardial cells in developing rat heart by P [Met5]enkephalin. Am J Physiol 1996;271:R122-R129.[Web of Science][Medline]
[Order article via Infotrieve]
- Zagon IS, Verderame MF, McLaughlin PJ The biology of the opioid growth factor receptor (OGFr). Brain Res Brain Res Rev 2002;38:351-76.[CrossRef][Medline]
[Order article via Infotrieve]
- Pei JM, Wang YM, Zhu YL, Chen M., Wong TM Signaling pathway mediated by kappa-opioid receptor is impaired in cardiac hypertrophy. Acta Pharmacol Si 2001;22:887-95.
- Peart JN, Gross GJ Chronic exposure to morphine produces a marked cardioprotective phenotype in aged mouse hearts. Exp Gerontol 2004;39:1021-6.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- McLaughlin PJ Opioid antagonist modulation of rat heart development. Life Sci 1994;54:1423-31.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Zagon IS, McLaughlin PJ Naltrexone modulates growth in infant rats. Life Sci 1983;33:2449-54.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Erdos EG, Johnson AR, Boyden NT Hydrolysis of enkephalin by cultured human endothelial cells and by purified peptidyl dipeptidase. Biochem Pharmacol 1978;27:843-8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Erdos EG, Johnson AR, Boyden NT Inactivation of enkephalins: effect of purified peptidyl dipeptidase and cultured human endothelial cells. Adv Biochem Psychopharmacol 1978;18:45-9.[Medline]
[Order article via Infotrieve]
- Skidgel RA, Erdos EG Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies. Peptides 2004;25:521-5.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Solvd. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators. N Engl J Med 1992;327:685-91.[Abstract]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 8, No. 4,
153-159 (2007)
DOI: 10.3317/jraas.2007.030

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|